4 Min Read
Newly-minted Remedy CEO Jean-Charles Gaudechon, who was appointed in February, said the company has been smart to avoid “going too fast too quickly.”
During an earnings Q&A held shortly after the Alan Wake and Control maker published its Q1 fiscal results, Gaudechon said Control Resonant—which the studio previously confirmed had an initial estimated budget of around €50 million—has remained on track.
Appraising the current situation at the studio, which recently shelved multiplayer shooter FBC: Firebreak after it failed to attract players, Gaudechon said he has been impressed with Remedy’s ability to produce triple-A titles without breaking the bank.
“The team and the studio has done excellent work to stay on track. Has done excellent work to build a triple-A game on a relatively small budget. That’s something we’ve seen from Remedy before. That’s something we’ll see again from Remedy,” said Gaudechon.
Related:A risk-averse video game industry is failing marginalized developers
“Honestly, there’s something pretty incredible about the way games are being built at Remedy and are being thought through and managed. It has not always been the case, I know that. There have been some hiccups in the past. But the team has done incredible work on Control Resonant.”
Gaudechon said Remedy has been able to keep costs relatively low because it has its own game engine, Northlight, and internal processes built around the technology. Notably, he said the company has also resisted the urge to expand exponentially after delivering hits.
“One thing you can say about Remedy, is that Remedy has always been smart about not going too fast too quickly. You’ve seen that in other parts of the industry, unfortunately,” Gaudechon continued. “That’s when you take the risk of having to potentially downsize. What I can say today about the size of the team—the size of Remedy and the games we’re making—I think we’re pretty much the right size for it.”
Right now, Gaudechon said he’s focused on bringing Control Resonant to market. That means he has no desire to usher in sweeping change at the company, although he said there is always room for improvement within any organization.
“I’ve seen parts of Remedy I think can be improved at many different levels. Today, what’s really important is to keep a balance on what you can improve and when you do some of these improvements,” added Gaudechon.
“As I’ve said, right now the studio is in full execution mode and we need to be cautious with that and give the right support. A lot of this is gradual anyway. Today it’s more about protecting, supporting, and making sure that we stay on the right track without necessarily disrupting any of that. But, yes, there will be changes here or there […] which will help the studio perform even better in the future.”
Related:EVE Online’s cross-platform game engine framework is now fully open source
“We also want more players around the world to experience Remedy’s games”
Outlining his wider vision in Remedy’s earnings report for the first quarter ended March 31, 2026, Gaudechon said the company will double down on what makes it unique. In his words, that means focusing in on “creative identity, memorable IPs, and [a] commitment to delivering exceptional quality and originality.”
“We are more focused than ever on moving forward with franchise expansion, self-publishing, and commercial discipline to improve our business performance. The studio is in good shape to deliver on these pillars,” wrote Gaudechon.
The former EA exec also identified growth opportunities within China and other Asian markets, and said Remedy is currently working with “local partners” to better serve consumers in those regions.
“While our core markets remain a priority, we also want more players around the world to experience Remedy’s games,” he added.
Gaudechon said Remedy has made a “good start to an exciting year” during a quarter in which revenue totaled €13.1 million—a 1.9 percent decrease year-on-year—and operating profit fell to €1 million from €1.3 million. The quarter, however, remained profitable for the company.
Related:Rockstar accused of ignoring pay inequity, mandating crunch, and weaponizing bonuses
Discussing the performance of individual titles, Gaudechon said Control has now sold over 6 million copies worldwide after retaining “solid sales momentum.” He noted that Alan Wake 2 continues to earn royalties and said other titles in the franchise delivered “normal back-catalogue sales.”
“Remedy has a pivotal year ahead, and we are off to a good start. Our first quarter was profitable, our games on the market performed to our expectations and we’re making steady progress with our development projects,” continued Gaudechon.
“Delivering a high-quality Control Resonant with a successful launch is our top priority and we are on track for our 2026 launch. Our marketing activities and related spend will significantly intensify prior to the launch of the game.”
About the Author
Senior Editor, News, GameDeveloper.com
Game Developer news editor Chris Kerr is an award-winning reporter with over a decade of experience in the game industry. His byline has appeared in notable print and digital publications including Edge, Stuff, Wireframe, International Business Times, and PocketGamer.biz. Throughout his career, Chris has covered major industry events including GDC, PAX Australia, Gamescom, Paris Games Week, and Develop Brighton.
